Nortech SystemsNSYS +2.82%54 EBITDA Margin % is 1.15% as of Mar. 2026, which is 50% below its 10-year median of 2.31. GuruFocus rates NSYS with a GF Score™ of 54/100 and a GF Value™ of $9.25 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Nortech Systems ranks worse than 57.35% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nortech Systems's EBITDA for the
three
months ended in Mar. 2026 was $0.4 Mil. Nortech Systems's Revenue for the
three
months ended in Mar. 2026 was $30.3 Mil. Therefore, Nortech Systems's EBITDA margin for the quarter that ended in Mar. 2026 was 1.15%.
Nortech Systems (NAS:NSYS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nortech Systems EBITDA Margin % Related Terms
Nortech Systems EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Nortech Systems's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSYS vs MYO, NSPR, TELA: EBITDA Margin % Comparison
For the Medical Devices subindustry, Nortech Systems's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nortech Systems EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nortech Systems's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nortech Systems's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nortech Systems (NSYS) has a EBITDA Margin % of 1.15% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nortech Systems and its competitors. This is 50% below median its historical median of 2.31. Over the past decade, Nortech Systems' EBITDA Margin % has ranged from 0.94 to 9.02. According to the industry distribution chart, Nortech Systems ranks #468 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 57.4%.
Is Nortech Systems' EBITDA Margin % too high?
Nortech Systems' current EBITDA Margin % of 1.15% is 50% below median its 10-year median of 2.31. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 9.02. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Nortech Systems' value of 1.15% is 84.6% below this industry median. Based on the distribution chart, Nortech Systems ranks #468 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nortech Systems has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nortech Systems' EBITDA Margin % compare to MYO and NSPR?
According to the Medical Devices & Instruments industry distribution chart, Nortech Systems ranks #468 out of 816 companies for EBITDA Margin %. This places Nortech Systems in the lower half of its industry. The industry median EBITDA Margin % is 7.48. Nortech Systems' value of 1.15% is 84.6% below this benchmark. Historically, Nortech Systems' own EBITDA Margin % has ranged from 0.94 to 9.02 over the past decade. While the company's 10-year median is 2.31 vs. the industry median of 7.48, Nortech Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nortech Systems's current EBITDA Margin % of 1.15% is 84.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nortech Systems and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nortech Systems's current EBITDA Margin % is 1.15%, which is 50% below median its own 10-year median of 2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nortech Systems stock overvalued right now?
Based on GuruFocus' analysis, Nortech Systems (NSYS) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.25, compared to a current price of $16.42 — trading 77.5% above its estimated fair value. The current EBITDA Margin % is 1.15%, which is 50% below median its 10-year median of 2.31 and 84.6% below the Medical Devices & Instruments industry median of 7.48. Nortech Systems' overall GF Score™ is 54/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nortech Systems (NSYS), the current EBITDA Margin % is 1.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nortech Systems (NSYS) Overvalued in 2026?
Based on GuruFocus' analysis, Nortech Systems stock appears to be overvalued.
The current stock price of $16.42 is trading 77.5% above its estimated GF Value™ of $9.25.
GuruFocus considers Nortech Systems to be Significantly Overvalued.
Key valuation signals for NSYS:
EBITDA Margin %: 1.15% (50% below median its 10-year median of 2.31)
GF Value™: $9.25 vs. price of $16.42 (77.5% above fair value)
Industry Position: 84.6% below the Medical Devices & Instruments median (#468 of 816)
No single metric tells the full story. See the NSYS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
54GF Score
Get the complete analysis for NSYS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSYS has been successfully added to your 
